Johnson & Johnson (NYSE: JNJ), has broken ground on a $2 billion pharmaceutical manufacturing facility in Wilson, about 50 ...

Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the European Union (EU) to ...

As part of a new $55 billion investment nationally, pharmaceutical giant Johnson & Johnson is investing in a manufacturing ...

With its active pharmaceutical ingredient (API) facility “in a state of disrepair,” manufacturer Aspen Biopharma Labs’ operations have ground to a halt in the U.S., according to a recent FDA reprim | ...

In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS’ Saint-Beauzire site provides tailored solutions for pre-clinical and clinical trials and small ...

The API Innovation Center (APIIC) today released an industry white paper detailing the United States’ overreliance on foreign production of essential medicines and presenting a comprehensive plan to ...

SMS Pharmaceuticals rose 1.79% to Rs 221.80 after company announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its API manufacturing facility located in ...